- Home
- DMLP vs BLFS Comparison
DMLP vs BLFS Comparison
Compare DMLP & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMLP
- BLFS
- Stock Information
- Founded
- DMLP 2003
- BLFS 1987
- Country
- DMLP United States
- BLFS United States
- Employees
- DMLP N/A
- BLFS N/A
- Industry
- DMLP Oil & Gas Production
- BLFS Medical/Dental Instruments
- Sector
- DMLP Energy
- BLFS Health Care
- Exchange
- DMLP Nasdaq
- BLFS Nasdaq
- Market Cap
- DMLP 1.1B
- BLFS 1.3B
- IPO Year
- DMLP N/A
- BLFS 1989
- Fundamental
- Price
- DMLP $24.35
- BLFS $28.16
- Analyst Decision
- DMLP
- BLFS Strong Buy
- Analyst Count
- DMLP 0
- BLFS 7
- Target Price
- DMLP N/A
- BLFS $30.86
- AVG Volume (30 Days)
- DMLP 90.1K
- BLFS 395.1K
- Earning Date
- DMLP 11-07-2025
- BLFS 11-11-2025
- Dividend Yield
- DMLP 13.51%
- BLFS N/A
- EPS Growth
- DMLP N/A
- BLFS N/A
- EPS
- DMLP 1.71
- BLFS N/A
- Revenue
- DMLP $161,859,000.00
- BLFS $93,468,000.00
- Revenue This Year
- DMLP N/A
- BLFS $26.07
- Revenue Next Year
- DMLP N/A
- BLFS $16.86
- P/E Ratio
- DMLP $13.96
- BLFS N/A
- Revenue Growth
- DMLP 4.04
- BLFS 68.16
- 52 Week Low
- DMLP $23.63
- BLFS $19.10
- 52 Week High
- DMLP $34.88
- BLFS $29.55
- Technical
- Relative Strength Index (RSI)
- DMLP 42.94
- BLFS 61.79
- Support Level
- DMLP $23.63
- BLFS $26.87
- Resistance Level
- DMLP $24.40
- BLFS $29.04
- Average True Range (ATR)
- DMLP 0.50
- BLFS 1.00
- MACD
- DMLP -0.09
- BLFS 0.09
- Stochastic Oscillator
- DMLP 31.07
- BLFS 74.96
About DMLP Dorchester Minerals L.P. Common Units Representing Limited Partnership Interests
Dorchester Minerals LP operates as the owner of producing and non-producing crude oil and natural gas mineral, royalty, overriding royalty, net profits and leasehold interests. The company generates revenues from royalties, net profits interests, lease bonus, and others. It has leasehold interests in approximately 592 counties and parishes in around 28 states.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.